Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate transporter 1 (GLT-1), also known as Excitatory Amino Acid Transporter 2 (EAAT2), is a high-affinity glutamate transporter predominantly found in astrocytes within the central nervous system. It plays a critical role in regulating extracellular glutamate concentrations by transporting glutamate from the synaptic cleft, thereby preventing excitotoxicity. GLT-1 dysfunction is implicated in several neurological disorders, making it a therapeutic target for neuroprotection.
Upregulation of GLT-1 expression/activity (Ceftriaxone); Noncompetitive inhibition of conformational changes (UCPH101)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate Transporter 1 (GLT-1).